More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.
Read More
COVID-19 in North America
A State Playbook to Transform America’s Rural Health Workforce
An informative playbook to build, retain, and support the rural health workforce through GYO pipelines, pathways, residencies, telehealth, and team-based care.
CMS Crushing Fraud Chili Cookoff Showcase 2025
Abt Global is a finalist at the CMS Crushing Fraud Chili Cookoff Showcase 2025.
Abt Named Finalist in CMS “Crushing Fraud” Innovation Challenge
Abt Global has been selected as one of 10 finalists in the Centers for Medicare and Medicaid Services’ Crushing Fraud Chili Cook-Off.
Modernizing America’s Waterborne Commerce Intelligence
Abt’s partnership with USACE’s Waterborne Commerce Statistics Center strengthens America’s capacity to deliver reliable navigation data through AI-enabled waterborne commerce intelligence.